US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE PHARMA GROUP

17.00

-0.3200-1.85%

Post-market: 17.000.00000.00%19:30 EDT

Volume:2K

Turnover:31.41K

Market Cap:1.59B

PE:-8.61

High:17.44

Open:17.15

Low:17.00

Close:17.32

52wk High:48.45

52wk Low:16.36

Shares:93.33M

Float Shares:71.58M

Volume Ratio:0.19

T/O Rate:0.00%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9750

EPS(LYR):-1.9957

ROE:-236.63%

ROA:-28.04%

PB:19.17

PE(LYR):-8.52

Loading ...

Overview Company News Filings

ASCENTAGE-B (06855) Unveils Four Preclinical Advances at 2026 AACR Annual Meeting, Highlighting Potential of Multiple Combination Therapies

Beneath the Glossy Sales Figures: ASCENTAGE PHARMA GROUP's Profitability Crisis and Three Critical Risks

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascentage Pharma Group International Unsponsored ADR (AAPG)

Piper Sandler Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)

Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says

MT Newswires Live

Stock Track | Ascentage Pharma Group Soars 8.56% Intraday on Positive Analyst Ratings

BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)

Sector Update: Health Care

MT Newswires Live

Ascentage Pharma's 2025 Loss Widens, Revenue Falls

MT Newswires Live

ASCENTAGE-B Reports Strong Growth Driven by Dual Commercial Engines

Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates

ASCENTAGE-B to Present Four Preclinical Studies at 2026 AACR Annual Meeting

Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026

Ascentage Pharma initiated with a Buy at BTIG

Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026

Ascentage Pharma to Participate in Three Upcoming Investor Conferences

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/AAPG/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AAPG","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","market":"US","secType":"STK","nameCN":"ASCENTAGE PHARMA GROUP","latestPrice":17,"timestamp":1787342400000,"preClose":17.32,"halted":0,"volume":1838,"hourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":42,"amount":715.11,"timestamp":1787355007860,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.018475750577367223,"floatShares":71582800,"shares":93330405,"eps":-1.975,"marketStatus":"Not Yet Opened","change":-0.32,"latestTime":"08-21 16:00:00 EDT","open":17.15,"high":17.4435,"low":17,"amount":31414.382856000004,"amplitude":0.025606,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.975,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":4,"listingDate":1737694800000,"exchange":"NASDAQ","adjPreClose":17.32,"postHourTrading":{"tag":"盘后","latestPrice":17,"preClose":17,"latestTime":"19:30 EDT","volume":42,"amount":715.11,"timestamp":1787355007860,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.19047816661684647},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AAPG\",,,,,undefined,":{"symbol":"AAPG","floatShares":71582800,"roa":"-28.04%","roe":"-236.63%","lyrEps":-1.995679,"volumeRatio":0.19047816661684647,"shares":93330405,"dividePrice":0,"high":17.4435,"amplitude":0.025606,"preClose":17.32,"low":17,"week52Low":16.36,"pbRate":"19.17","psRate":"16.60","week52High":48.45,"institutionHeld":0,"latestPrice":17,"eps":-1.975,"divideRate":0,"volume":1838,"delay":0,"ttmEps":-1.975,"open":17.15,"prevYearClose":26.24,"prevWeekClose":19,"prevMonthClose":17.425,"prevQuarterClose":17.56,"fiveDayClose":19,"twentyDayClose":18.29,"sixtyDayClose":20.9},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AAPG\",params:#limit:5,,,undefined,":[{"date":"2026-08-19","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2026/06","expectedEps":-0.44,"defaultRemindTime":1787126400000,"name":null,"time":"Pre-MKt","dateTimestamp":1787112000000,"actualEps":null},{"date":"2026-03-25","symbol":"AAPG","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1774468800000,"name":null,"time":"Post-Mkt","dateTimestamp":1774411200000,"actualEps":null},{"market":"US","date":"2025-08-20","symbol":"AAPG","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"date":"2025-03-27","symbol":"AAPG","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1743062400000,"name":null,"time":"Pre-MKt","dateTimestamp":1743048000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AAPG\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AAPG\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.7778,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7778,"analysts":9,"updateTime":1781150400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AAPG\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AAPG","date":"2026-08-21","current":-8.607595,"percent":1,"low":-76.454813,"twenty":-35.947221,"median":-19.05933,"eighty":-11.591162,"high":-7.057849,"avg":-25.155962,"sd":16.844147,"marketCap":1541157743.83},"quantilePoints":[{"date":"2025-01-31","current":-29.751262,"twenty":-29.75286,"median":-29.751983,"eighty":-29.751262,"marketCap":1478269659.08},{"date":"2025-02-07","current":-32.664532,"twenty":-32.365221,"median":-31.242401,"eighty":-29.752127,"marketCap":1614694688.16},{"date":"2025-02-14","current":-31.1828,"twenty":-32.258438,"median":-31.212601,"eighty":-29.752938,"marketCap":1540476496.81},{"date":"2025-02-21","current":-36.382297,"twenty":-32.721933,"median":-31.802125,"eighty":-29.819279,"marketCap":1806628873.73},{"date":"2025-02-28","current":-33.43308,"twenty":-34.468465,"median":-32.375664,"eighty":-30.230932,"marketCap":1654638501.56},{"date":"2025-03-07","current":-34.452224,"twenty":-34.328072,"median":-32.712367,"eighty":-30.892818,"marketCap":1712841480.27},{"date":"2025-03-14","current":-33.065652,"twenty":-34.096417,"median":-32.760201,"eighty":-31.20664,"marketCap":1644428002.08},{"date":"2025-03-21","current":-32.72391,"twenty":-34.124503,"median":-32.947597,"eighty":-31.448698,"marketCap":1626713850.02},{"date":"2025-03-28","current":-33.955809,"twenty":-34.124503,"median":-33.010704,"eighty":-31.793328,"marketCap":1894714451.86},{"date":"2025-04-04","current":-35.921968,"twenty":-34.855052,"median":-33.21342,"eighty":-31.979778,"marketCap":2000185586.04},{"date":"2025-04-11","current":-29.511221,"twenty":-34.370118,"median":-33.010704,"eighty":-30.892818,"marketCap":1635879540.94},{"date":"2025-04-17","current":-29.520055,"twenty":-34.225935,"median":-32.760201,"eighty":-30.07059,"marketCap":1639709582.7},{"date":"2025-04-25","current":-41.553435,"twenty":-35.045268,"median":-32.920123,"eighty":-30.119556,"marketCap":2311372741.24},{"date":"2025-05-02","current":-38.492689,"twenty":-35.554336,"median":-33.187028,"eighty":-30.682879,"marketCap":2146245101.28},{"date":"2025-05-09","current":-37.35919,"twenty":-36.170996,"median":-33.361942,"eighty":-30.776099,"marketCap":2093177176.92},{"date":"2025-05-16","current":-35.007117,"twenty":-35.955639,"median":-33.43308,"eighty":-31.102567,"marketCap":1969122395.28},{"date":"2025-05-23","current":-39.338512,"twenty":-36.352488,"median":-33.608398,"eighty":-31.19472,"marketCap":2213435510.22},{"date":"2025-05-30","current":-38.856398,"twenty":-37.35919,"median":-33.992043,"eighty":-31.242401,"marketCap":2192363417.29},{"date":"2025-06-06","current":-42.814884,"twenty":-37.865895,"median":-34.141844,"eighty":-31.758144,"marketCap":2419987007.19},{"date":"2025-06-13","current":-48.171029,"twenty":-38.492689,"median":-34.477812,"eighty":-31.846105,"marketCap":2722575737.57},{"date":"2025-06-20","current":-55.929302,"twenty":-38.862859,"median":-34.635358,"eighty":-32.113451,"marketCap":3154688383.5},{"date":"2025-06-27","current":-59.787237,"twenty":-39.399619,"median":-35.123604,"eighty":-32.336589,"marketCap":3381751544.24},{"date":"2025-07-03","current":-64.068526,"twenty":-41.436089,"median":-35.258863,"eighty":-32.429915,"marketCap":3624015684.35},{"date":"2025-07-11","current":-59.084566,"twenty":-43.897892,"median":-35.501693,"eighty":-32.48435,"marketCap":3338745741.38},{"date":"2025-07-18","current":-61.880278,"twenty":-48.308604,"median":-35.791073,"eighty":-32.545465,"marketCap":3494679880.36},{"date":"2025-07-25","current":-58.315576,"twenty":-54.849764,"median":-35.921968,"eighty":-32.616809,"marketCap":3304687864.64},{"date":"2025-08-01","current":-60.559654,"twenty":-57.422661,"median":-36.233253,"eighty":-32.655768,"marketCap":3410643633.03},{"date":"2025-08-08","current":-69.260076,"twenty":-59.023969,"median":-36.597865,"eighty":-32.679287,"marketCap":3910472388.03},{"date":"2025-08-15","current":-72.346957,"twenty":-59.602544,"median":-37.391167,"eighty":-32.709995,"marketCap":4086922647.44},{"date":"2025-08-22","current":-26.724459,"twenty":-60.097702,"median":-37.493155,"eighty":-32.679287,"marketCap":4314209810.62},{"date":"2025-08-29","current":-24.396919,"twenty":-59.865528,"median":-36.699167,"eighty":-32.48435,"marketCap":3966417985.85},{"date":"2025-09-05","current":-22.946281,"twenty":-59.664109,"median":-36.382297,"eighty":-31.979778,"marketCap":3724203040.4},{"date":"2025-09-12","current":-22.941741,"twenty":-59.475774,"median":-35.943012,"eighty":-31.122625,"marketCap":3735810338.07},{"date":"2025-09-19","current":-21.785524,"twenty":-59.316014,"median":-35.857966,"eighty":-29.943039,"marketCap":3550375801.58},{"date":"2025-09-26","current":-21.102028,"twenty":-59.062646,"median":-35.66937,"eighty":-29.751262,"marketCap":3428719452.06},{"date":"2025-10-03","current":-22.266298,"twenty":-59.025902,"median":-35.30284,"eighty":-28.699054,"marketCap":3625414266.5},{"date":"2025-10-10","current":-21.050291,"twenty":-58.738293,"median":-35.189473,"eighty":-26.732175,"marketCap":3423480133.18},{"date":"2025-10-17","current":-19.80269,"twenty":-58.191808,"median":-34.731922,"eighty":-24.468638,"marketCap":3221889328.22},{"date":"2025-10-24","current":-19.801335,"twenty":-57.904825,"median":-34.477812,"eighty":-23.569995,"marketCap":3222890223.42},{"date":"2025-10-31","current":-19.321494,"twenty":-57.532716,"median":-34.141844,"eighty":-22.943557,"marketCap":3150231208.59},{"date":"2025-11-07","current":-18.112503,"twenty":-56.69325,"median":-33.992043,"eighty":-22.558349,"marketCap":2949090425.48},{"date":"2025-11-14","current":-19.583345,"twenty":-55.920234,"median":-33.485756,"eighty":-22.342071,"marketCap":3199584585.23},{"date":"2025-11-21","current":-17.547753,"twenty":-55.765092,"median":-33.408485,"eighty":-22.122489,"marketCap":2860955000.96},{"date":"2025-11-28","current":-18.539078,"twenty":-55.318442,"median":-33.361942,"eighty":-21.796498,"marketCap":3034915066.08},{"date":"2025-12-05","current":-18.33416,"twenty":-53.27811,"median":-33.187028,"eighty":-21.590149,"marketCap":3005486168.49},{"date":"2025-12-12","current":-17.062052,"twenty":-48.796704,"median":-32.920123,"eighty":-21.073758,"marketCap":2802301628.68},{"date":"2025-12-19","current":-16.188794,"twenty":-48.517949,"median":-32.72391,"eighty":-20.125041,"marketCap":2665447409.6},{"date":"2025-12-26","current":-15.347054,"twenty":-48.514967,"median":-32.664532,"eighty":-19.801335,"marketCap":2537308174.25},{"date":"2026-01-02","current":-14.520508,"twenty":-48.239817,"median":-32.57809,"eighty":-19.656119,"marketCap":2406972911.39},{"date":"2026-01-09","current":-15.636938,"twenty":-46.480698,"median":-32.420873,"eighty":-19.300607,"marketCap":2595562368.02},{"date":"2026-01-16","current":-14.792082,"twenty":-45.997596,"median":-31.846105,"eighty":-19.073232,"marketCap":2461528990.12},{"date":"2026-01-23","current":-14.451393,"twenty":-45.706429,"median":-31.242401,"eighty":-18.892753,"marketCap":2402559084.95},{"date":"2026-01-30","current":-13.594278,"twenty":-43.897892,"median":-30.891003,"eighty":-18.486342,"marketCap":2268064814.82},{"date":"2026-02-06","current":-13.215954,"twenty":-42.7913,"median":-29.979764,"eighty":-18.329609,"marketCap":2208187061.91},{"date":"2026-02-13","current":-13.314281,"twenty":-42.590497,"median":-29.752899,"eighty":-18.136415,"marketCap":2236446544.83},{"date":"2026-02-20","current":-13.322258,"twenty":-42.10164,"median":-29.751262,"eighty":-17.934704,"marketCap":2235292402.77},{"date":"2026-02-27","current":-13.022247,"twenty":-41.475205,"median":-29.511221,"eighty":-17.157024,"marketCap":2206480506.48},{"date":"2026-03-06","current":-12.669019,"twenty":-41.161756,"median":-28.176938,"eighty":-16.734267,"marketCap":2131116747.44},{"date":"2026-03-13","current":-12.688953,"twenty":-40.378179,"median":-26.74375,"eighty":-16.137082,"marketCap":2141399622.46},{"date":"2026-03-20","current":-11.937263,"twenty":-39.521832,"median":-25.944924,"eighty":-15.566094,"marketCap":2005434649.33},{"date":"2026-03-27","current":-12.020857,"twenty":-39.289753,"median":-24.396919,"eighty":-15.439715,"marketCap":2161491459.44},{"date":"2026-04-02","current":-13.548587,"twenty":-39.152841,"median":-23.731199,"eighty":-15.186721,"marketCap":2444436047.79},{"date":"2026-04-10","current":-12.693217,"twenty":-38.895939,"median":-23.387346,"eighty":-14.745986,"marketCap":2308441702.51},{"date":"2026-04-17","current":-13.620079,"twenty":-38.882244,"median":-22.946281,"eighty":-14.465216,"marketCap":2481253103.51},{"date":"2026-04-24","current":-12.083101,"twenty":-38.84865,"median":-22.780777,"eighty":-14.008358,"marketCap":2199221373.05},{"date":"2026-05-01","current":-11.527627,"twenty":-38.758432,"median":-22.499202,"eighty":-13.791914,"marketCap":2098243441.9},{"date":"2026-05-08","current":-10.968155,"twenty":-38.515761,"median":-22.389807,"eighty":-13.684651,"marketCap":2004129088.99},{"date":"2026-05-15","current":-10.082774,"twenty":-38.444183,"median":-22.266298,"eighty":-13.539734,"marketCap":1846775928.57},{"date":"2026-05-22","current":-10.707594,"twenty":-38.225934,"median":-22.137659,"eighty":-13.395768,"marketCap":1956144727.44},{"date":"2026-05-29","current":-10.055476,"twenty":-38.129026,"median":-21.923528,"eighty":-13.314281,"marketCap":1843351578.24},{"date":"2026-06-05","current":-8.909894,"twenty":-37.937734,"median":-21.785524,"eighty":-13.216389,"marketCap":1635661877.38},{"date":"2026-06-12","current":-8.93641,"twenty":-37.865895,"median":-21.603031,"eighty":-13.157057,"marketCap":1639076784.73},{"date":"2026-06-18","current":-8.353042,"twenty":-37.752402,"median":-21.278471,"eighty":-13.101714,"marketCap":1535636323.4},{"date":"2026-06-26","current":-7.824164,"twenty":-37.62092,"median":-21.066691,"eighty":-13.023474,"marketCap":1430786980.62},{"date":"2026-07-02","current":-8.952074,"twenty":-37.472757,"median":-20.67449,"eighty":-12.989985,"marketCap":1637864621.41},{"date":"2026-07-10","current":-9.338033,"twenty":-37.371981,"median":-19.946515,"eighty":-12.776282,"marketCap":1707700089.2},{"date":"2026-07-17","current":-9.151372,"twenty":-36.963176,"median":-19.801335,"eighty":-12.672971,"marketCap":1678950333.06},{"date":"2026-07-24","current":-9.04646,"twenty":-36.577605,"median":-19.676085,"eighty":-12.361815,"marketCap":1659751775.25},{"date":"2026-07-31","current":-8.626077,"twenty":-36.450857,"median":-19.539859,"eighty":-12.179575,"marketCap":1585151449.4},{"date":"2026-08-07","current":-9.281807,"twenty":-36.322679,"median":-19.321494,"eighty":-11.987055,"marketCap":1708580872.07},{"date":"2026-08-14","current":-9.158138,"twenty":-36.125575,"median":-19.172925,"eighty":-11.879713,"marketCap":1687515849.52},{"date":"2026-08-21","current":-7.057849,"twenty":-35.947221,"median":-19.05933,"eighty":-11.591162,"marketCap":1541157743.83}],"updateTime":1787510287449},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AAPG\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1169155551","title":"ASCENTAGE-B (06855) Unveils Four Preclinical Advances at 2026 AACR Annual Meeting, Highlighting Potential of Multiple Combination Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=1169155551","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169155551?lang=en_us&edition=fundamental","pubTime":"2026-04-20 07:16","pubTimestamp":1776640579,"startTime":"0","endTime":"0","summary":"ASCENTAGE-B (06855) announced that it will present four preclinical research findings in poster sessions at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The conference is...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","06855","BK4139","AAPG","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116756196","title":"Beneath the Glossy Sales Figures: ASCENTAGE PHARMA GROUP's Profitability Crisis and Three Critical Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=1116756196","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116756196?lang=en_us&edition=fundamental","pubTime":"2026-04-17 19:11","pubTimestamp":1776424261,"startTime":"0","endTime":"0","summary":"On the track of domestic innovative drug development, ASCENTAGE PHARMA GROUP (06855.HK) was once one of the brightest stars. However, its recently disclosed 2025 annual report reveals a classic...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627243025","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2627243025","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627243025?lang=en_us&edition=fundamental","pubTime":"2026-04-13 19:50","pubTimestamp":1776081011,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS), Zimmer Biomet Holdings (ZBH) and Ascen...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zimmer-biomet-holdings-zbh-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-hims-hers-health-hims-zimmer-biomet-holdings-zbh-and-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ZBH","BK4585","IE0002270589.USD","IE00B19Z3581.USD","LU0006061336.USD","LU0980610538.SGD","BK4137","BK4581","IE00B19Z3B42.SGD","AAPG","LABU","LU0708994859.HKD","BK4082","LU1267930573.SGD","HMYY","LU0029874061.USD","LU0477156953.USD","IE00B7SZLL34.SGD","BK4196","LU0029864427.USD","BK4588","HIYY","BK4566","LU0128526141.USD","HIMZ","LU0792757196.USD","XBI","LU1267930490.SGD","HIMS","LU0128525929.USD","LU0130102774.USD","LU0211328371.USD","LU0130517989.USD","LU0211327993.USD","LU0310799852.SGD","BK4504","LU0310800379.SGD","LU1267930813.SGD","LU0648001328.SGD","LU0889566641.SGD","HIMY","LU1201861249.SGD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626194124","title":"Piper Sandler Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626194124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626194124?lang=en_us&edition=fundamental","pubTime":"2026-04-10 19:16","pubTimestamp":1775819808,"startTime":"0","endTime":"0","summary":"In a report released today, Biren Amin from Piper Sandler maintained a Buy rating on Ascentage Pharma Group International Unsponsored ADR, with a p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/piper-sandler-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622687590","title":"Ascentage Pharma Builds Momentum With 2 'Potential Blockbuster' Drugs, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2622687590","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622687590?lang=en_us&edition=fundamental","pubTime":"2026-03-27 23:26","pubTimestamp":1774625210,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group (AAPG) is entering 2026 with growing commercial momentum in China and a pipeline nearing major global readouts, including two \"potential blockbuster\" drugs, Oppenheimer said Fri","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4127","OPY","BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116979923","title":"Stock Track | Ascentage Pharma Group Soars 8.56% Intraday on Positive Analyst Ratings","url":"https://stock-news.laohu8.com/highlight/detail?id=1116979923","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116979923?lang=en_us&edition=fundamental","pubTime":"2026-03-27 22:33","pubTimestamp":1774621984,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group's stock surged 8.56% during intraday trading on Friday, driven by positive analyst sentiment from two major financial firms.Truist Financial analyst Gregory Renza maintained a...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622823324","title":"BTIG Remains a Buy on Ascentage Pharma Group International Unsponsored ADR (AAPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2622823324","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622823324?lang=en_us&edition=fundamental","pubTime":"2026-03-27 18:57","pubTimestamp":1774609065,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee reiterated a Buy rating on Ascentage Pharma Group International Unsponsored ADR yesterday and set a price target of $48...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/btig-remains-a-buy-on-ascentage-pharma-group-international-unsponsored-adr-aapg-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622850096","title":"Sector Update: Health Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2622850096","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622850096?lang=en_us&edition=fundamental","pubTime":"2026-03-26 20:56","pubTimestamp":1774529810,"startTime":"0","endTime":"0","summary":"Health care stocks were leaning lower premarket Thursday, with the State Street Health Care Select Sector SPDR ETF  down 0.2% and the iShares Biotechnology ETF  declining by 0.7%.Ascentage Pharma Group  shares were down more than 2% after the company reported a wider 2025 loss as revenue declined during the period.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0034235188.USD","BK4139","LU0061475181.USD","FDN","BK4135","IE00B64PRP62.GBP","STT","LU1894683264.USD","BK4581","AAPG","BK4550","LU1894683348.USD","IE00BGHQF748.EUR","IE00B3QW5Z07.USD","XBI","IBB","LU1883839398.USD","XLV","BK4585","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622834405","title":"Ascentage Pharma's 2025 Loss Widens, Revenue Falls","url":"https://stock-news.laohu8.com/highlight/detail?id=2622834405","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622834405?lang=en_us&edition=fundamental","pubTime":"2026-03-26 15:47","pubTimestamp":1774511272,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group  reported a 2025 loss late Wednesday of 3.49 Chinese renminbi  per diluted share, widening from a loss of 1.34 renminbi a year earlier.Two analysts polled by FactSet expected 2.22 renminbi.Revenue for the year ended Dec. 31 was 574.1 million renminbi, compared with 980.7 million renminbi a year earlier.Four analysts polled by FactSet expected 525.3 million renminbi.As of Dec. 31, 2025, cash and bank balances were $353.2 million, compared with $172.8 million a year earlier.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1189397132","title":"ASCENTAGE-B Reports Strong Growth Driven by Dual Commercial Engines","url":"https://stock-news.laohu8.com/highlight/detail?id=1189397132","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189397132?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:32","pubTimestamp":1774481547,"startTime":"0","endTime":"0","summary":"On March 26, leading innovative drug company ASCENTAGE PHARMA GROUP released its full-year 2025 results. During the reporting period, the company achieved total revenue of 574 million Chinese yuan,...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","06855","BK4139","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622888069","title":"Press Release: Ascentage Pharma Reports Full Year 2025 Unaudited Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2622888069","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622888069?lang=en_us&edition=fundamental","pubTime":"2026-03-26 07:00","pubTimestamp":1774479600,"startTime":"0","endTime":"0","summary":"-- Product sales and commercial rights revenues in 2025 increased 90%. -- Sales of Olverembatinib increased 81% year-over-year to US$62.2 million. -- Sales of Lisaftoclax since launch during last five months of 2025 were. Dr. Dajun Yang, Chairman and Chief Executive Officer of Ascentage Pharma, said, \"2025 was a year of significant execution in advancing our mission to deliver innovative therapies to patients worldwide. We advanced our commercialization strategy as Olverembatinib gained significant traction after receiving NRDL coverage expansion, which has markedly enhanced affordability and accessibility for patients in China. We launched Lisaftoclax in China in late July 2025 shortly after receiving regulatory approval and are gaining market adoption as we actively pursue the inclusion of Lisaftoclax in China's NRDL.\". Olverembatinib  is a novel, next-generation TKI and the first third-generation BCR-ABL1 TKI approved in China for treatment of patients with chronic myeloid leukemia ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LABU","BK4218","BK4139","BK4585","BK4081","EMA","5BI.SI","BK4181","BK1574","LU1223082196.USD","CDE","BK1161","BK6008","LU1223083913.SGD","BK6514","PK","BK4017","AAPG","BK4588","06855","LU1223082519.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134901961","title":"ASCENTAGE-B to Present Four Preclinical Studies at 2026 AACR Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1134901961","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134901961?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:20","pubTimestamp":1773793217,"startTime":"0","endTime":"0","summary":"ASCENTAGE-B (06855) announced that four of its preclinical research advancements have been selected for presentation at the 2026 American Association for Cancer Research (AACR) Annual Meeting. The...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","06855","BK4139","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620640432","title":"Ascentage Pharma to Present Data From Four Preclinical Studies In Its Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2620640432","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620640432?lang=en_us&edition=fundamental","pubTime":"2026-03-18 08:00","pubTimestamp":1773792000,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, March  17, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial stage, integrated biopharmaceutical company ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/18/3257844/0/en/Ascentage-Pharma-to-Present-Data-From-Four-Preclinical-Studies-In-Its-Innovative-Pipeline-at-American-Association-of-Cancer-Research-AACR-Annual-Meeting-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4117","AFG","BK4107","BK4201","EC","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618975797","title":"Ascentage Pharma initiated with a Buy at BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2618975797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618975797?lang=en_us&edition=fundamental","pubTime":"2026-03-12 04:29","pubTimestamp":1773260978,"startTime":"0","endTime":"0","summary":"BTIG analyst Jeet Mukherjee initiated coverage of Ascentage Pharma (AAPG) with a Buy rating and $48 price target The firm says the China-built biop...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/ascentage-pharma-initiated-with-a-buy-at-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618942948","title":"Ascentage Pharma to Report Full Year 2025 Unaudited Financial Results and Provide Business Updates on March 25, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2618942948","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618942948?lang=en_us&edition=fundamental","pubTime":"2026-03-11 20:00","pubTimestamp":1773230400,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, March  11, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred herein as “Ascentage Pharma,” the “Co","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/03/11/3253683/0/en/Ascentage-Pharma-to-Report-Full-Year-2025-Unaudited-Financial-Results-and-Provide-Business-Updates-on-March-25-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPG","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2613978243","title":"Ascentage Pharma to Participate in Three Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2613978243","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613978243?lang=en_us&edition=fundamental","pubTime":"2026-02-23 21:00","pubTimestamp":1771851600,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md. and SUZHOU, China, Feb.  23, 2026  (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”),a global, commercial stage, ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/23/3242582/0/en/Ascentage-Pharma-to-Participate-in-Three-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AAPG"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":56,"code":"91000000","status":"200"}]}}